INTRODUCTION
Cyclic hematopoiesis in grey collie dogs serves as a model for the study of the regulation of blood cell production by the bone marrow. The regular 11-12-d cycling ofall the blood cell counts appears to be caused by a periodic change in marrow production rates (1) (2) (3) , not an abnormality in the rate of destruction or sequestration of cells in the circulation (2, 4, 5) . The cycle length for reticulocytes, platelets, neutrophils, monocytes, and lymphocytes is precisely the same but the pattern of cyclic variation for each cell line is different, implicating the pluripotent stem cell as the site of the defect in this disease (3) . Marrow transplantation studies have shown that the disorder can be eliminated by total body irradiation and bone marrow transplantation from a normal dog (6) , and that the blood cycling can be produced in previously normal dogs by irradiation and infusion of grey collie marrow cells (7) . Therefore, alteration ofthe intrinsic regulation of the stem cell pool or pools is thought to produce this autosomal recessive disease (4, 8, 9) .
In 1974, Maloney et al. (10) reported that progressively increasing daily doses of endotoxin abrogate the cycling of neutrophil counts in this disorder. We have confirmed this finding and observed that endotoxin eliminates the apparent cycling ofthe reticulocytes and platelets as well as the cycling of the neutrophil counts (11) . Bone marrow differential count fluctuations were also abrogated (11) . Thus, chronic endotoxin administration eliminates the remarkably stable oscillation of blood cell production typically seen in dogs with this disease.
To attempt to clarify the mechanism whereby endotoxin modifies cyclic hematopoiesis and to investigate further marrow regulation in this disease, we have studied blood neutrophil variation, blood and marrow granulocyte-macrophage precursor cells (colony-forming cells [CFUc] ),' and serum levels ofcolonystimulating activity (CSA) in grey collies with cyclic neutropenia and grey collies during chronic endotoxin treatment.
individual cages in temperature-controlled quarters for the duration of these studies. Normal mongrel dogs served as controls. Blood specimens were routinely drawn from the cephalic vein of unanesthetized dogs between 8:30 and 9:30 a.m. and intravenous injections were given, when indicated, immediately after specimen withdrawal.
Blood counts. Leukocyte counts were performed on EDTA-anticoagulated blood specimens with a Coulter counter (Coulter Electronics Inc., Hialeah, Fla.). 100 cell differential counts were performed on air-dried, Wright'sstained coverslip smears made with an automated spinner (Plat Engineering Co., Cheltenham, Pa.).
Bone marrow aspirates. For bone marrow studies, dogs were anesthetized with intravenous thiamylal sodium (Surital, Parke, Davis & Co., Detroit, Mich.), from 15 to 20 mg/kg. Marrow was aspirated in sterile fashion by No. 14 or No. 16 Rosenthal-type needle from the long bones and iliac crests directly into syringes that contained 100-200 U of beef lung heparin (Upjohn Co., Kalamazoo, Mich.). 500 cell differential counts of Wright-Giemsa-stained coverslip smears were made. For serial marrow aspirate studies, the bone marrow sites were rotated so that no bone was aspirated more often than once per week.
In vitro bone marrow culture. Growth of granulocytemacrophage precursor cells (CFUc) was performed by a modification of the method of Marsh et al. (12) . Tissue culture medium 199 with Hanks' balanced salt solution and L-glutamine (Microbiological Associates, Walkersville, Md.) was supplemented with L-asparagine, 40 ,tg/ml (ICN Nutritional Biochemicals, Cleveland, Ohio), pyruvate, 10 ,tM (Microbiological Associates), penicillin, 20 U/ml, and streptomycin, 20 ug/ml (referred to hereafter as "supplemented media").
Freshly aspirated heparinized marrow was diluted in 5 ml of supplemented media, layered over 3 ml of FicollHypaque solution (Ficoll, Pharmacia Fine Chemicals, Piscataway, N. J.; Hypaque, Winthrop Laboratories, Sterling Drug Co., New York) (d 1.074-1.076, osmolarity 295-300 mosM) and centrifuged at 400 g for 35 min at 4°C. The cells at the interface zone were removed, washed three times, and resuspended in supplemented media. Cells were counted by hemacytometer and cell suspensions diluted to 2 x 106 nucleated marrow cells/ml. 1 ml of a suspension that contained 2 x 105 nucleated marrow cells, 0.1 ml of fetal calf serum (Irvine Scientific, Santa Ana, Calif. and Microbiologic Associates), 0.1 ml of a stimulatory material (CSA, see below), and 0.3% agar (BactoAgar, Difco Laboratories, Detroit, Mich.) in supplemented media were placed in 35-mm plastic dishes (Falcon Labware, Div., Becton, Dickinson & Co., Oxnard, Calif.), allowed to gel at room temperature, and placed in a 37°C, 5% CO2, 100% humidity incubator (National Appliance Co., Portland, Oreg.) for [8] [9] [10] d. All assays were performed in triplicate. Colonies of >50 cells were counted with an inverted microscope and results expressed as colonies per plate or colonies per 2 x 105 nucleated marrow cells. The optimal quantity of stimulator added and the optimal duration of incubation were determined in preliminary experiments. The 8-10-d incubation period represented the time of maximal colony number after which the colony numbers gradually decreased. The stimulator concentration was varied from 2.5 to 30% and found to be maximal at 10%. Colonies growing under these conditions were individually plucked from the agar and stained with aceto-orcein or with MacNeal's tetrachrome by the method of Lord and Testa (13) (14) . Marrow cell suspensions at 5-10 x 106 cells/ml were incubated with 100 ,uCi of high specific activity [3H]TdR (>60 Ci/mM, New England Nuclear, Boston, Mass.) for 20 min at 37°C. The incorporation of labeled thymidine was stopped with large volume washes (x3) of supplemented media to which 5% fetal calf serum and 100 ,ug/ml unlabeled thymidine had been added. The pelleted, washed cells were finally resuspended at 2 x 106 cells/ml and plated as above in supplemented media that contained unlabeled thymidine (10 ,ug/ml). Percent thymidine suicide was calculated by comparison of colony growth in the [3H]TdR-treated and control unlabeled thymicdine-treated plates: percent suicide = control CFUc -[3H]TdR treated CFUc/control CFUc. Control plates to which both tritiated thymidine and excess unlabeled thymidine were added gave suicides of zero, demonstrating that nonspecific toxicity was not involved.
In vitro peripheral blood culture. Granulocyte-macrophage precursor cells (CFUc) were grown from blood cells prepared by Ficoll-Hypaque separations. Slight modifications of the above in vitro culture methods used for marrow cells were found to increase colony yields: blood CFUc were grown in single-layer plates that contained 20% fetal calf serum, 10% stimulator, 0.45% agar, and 2 x 106 nucleated cells/ml in supplemented media. Blood CFUc were expressed as number of colonies per milliliter of whole blood.
In vitro colony-growth stimulators. Serum from various sources, feeder layers that contained blood cells from normal dogs, and conditioned media prepared by several different methods from murine, human, and canine cells were tested for stimulatory activity. Dog serum served as the best stimulator of colony growth. Normal dog blood was collected aseptically, allowed to clot at room temperature in glass tubes for 2 h, separated by centrifugation, and the serum stored at -10°C until use. Serum was also collected at various times after the intravenous injection of 0.1 ug/kg or 5 ,ug/kg Salmonella typhosa endotoxin into normal dogs and processed similarly. Maximum colony growth was shown to occur with sera collected between 3 and 6 h after the larger dose of endotoxin. All serial studies reported here were performed with a single pool of postendotoxin dog serum (PEDS) obtained 4 h after a 5-,ug/kg dose.
Assay for CSA. CSA was determined by comparing the number of colonies stimulated to grow by a test serum to the number of colonies stimulated by the standard PEDS from a given marrow cell suspension. The "activity" of serum was normalized to allow comparison of different assay runs by the following formula: CSA = (colonies grown with test serum/colonies grown with PEDS in same assay) x mean number of colonies, grown with PEDS in the 20 test assays.
Endotoxin administration. Concentrated endotoxin (Lipopolysacchari(le XV from S. typhosa 0901, Lot 3124-25, Difco Laboratories, Detroit, Mich.) was diluted to 500 g.g/ml in normal saline and stored at -10°C. Dilutions of <500 ,ug/ml were stored no more than 2 wk before use, and very diluted endotoxin doses (<1 ,ug/ml) were made up immediately before injection. Two grey collies and two normal dogs were given individual doses of endotoxin at 0.1 ,ug/kg to study the acute effects of this endotoxin dose (singleinjection studies). Three other normal dogs were also given single endotoxin doses at 5 ,ug/kg. Endotoxin was administered intravenously once daily to two grey collies starting at 0.0005 ,ug/kg per d and increased geometrically to 0. counts at 4-6 h after intravenous endotoxin at 0.1 jig/kg and no difference in the pattern ofcount changes (Table  I) . When grey collies were neutropenic, increments were essentially zero as reported previously (2) .
Chronic endotoxin treatment resulted in marked changes in the pattern of neutrophil counts. The periodic changes in total neutrophil count of the grey collies were replaced by stable counts, whereas in normal dogs the circulating neutrophil counts were increased to a level above their base-line values (Fig. 1, days 50-100 ). The mean neutrophil counts of grey collies given endotoxin chronically were not different from untreated grey collies, whereas normal dogs showed a 42% increase in mean neutrophil count ( Fig. 1 and Table I ). The increments in neutrophil counts at 4 and 6 h after the single endotoxin doses also were tabulated for both grey collies and normals (Table I) . Although the absolute values of the peak postendotoxin increments in the singleinjection studies were greater in the grey collies than in the normals, the peak neutrophil counts at 6 h after endotoxin were very nearly the same. The postendotoxin increments in neutrophil counts during chronic endotoxin treatment, however, were much larger in the normals than in the grey collies (Table  I) . When these numbers are represented as proportionate changes, the increase in neutrophil counts after chronic endotoxin injections appear qualitatively similar in grey collies and normals (70 and 200% increments, respectively).
Bone marrow and blood CFUc and endotoxin. The characteristic cycle of blood neutrophil counts in a grey collie was associated with an inverse rising and falling of simultaneous bone marrow CFUc (Fig.  2) . When multiple cycles from five grey collies were averaged by cycle day and plotted with a representative neutrophil cycle, marrow CFUc numbers peaked on days 2-3 during the neutrophil nadir and decreased to a nadir on days 6-8 at the time of blood neutrophilia (Fig. 3, middle panel) . Serial marrow studies on three normal dogs did not show evidence of cycling. The mean value for CFUc for 30 specimens in four normal dogs was 181±9 colonies per 2 x 105 nucleated marrow cells (Fig. 3) .
Blood CFUc numbers in grey collies averaged by cycle day showed a definite nadir on cycle days 2-3 with a peak on days 6 and 7 (Fig. 3, lower  panel) . In normal dogs serial studies of blood CFUc do not show periodicity; the mean value for 22 specimens in three dogs was 42±5 colonies/ml blood (Fig. 3) .
In contrast to these data, the bone marrow CFUc numbers during chronic endotoxin treatment were markedly altered. In no case were cycles such as that seen in Fig. 2 noted. When averaged by cycle day the "peak-nadir" pattern in the grey collies was lost and the curve looked like a curve showing CFUc numbers in a normal dog over any 2-wk period (Fig. 4, middle panel) . Mean marrow CFUc in grey collies on endotoxin were 139±7.9 per 2 x 105 cells, not different from untreated grey collies, 125±10.5 (P > 0.25). When normal dogs given chronic endotoxin treatment were assayed, marrow CFUc levels were 208±11 colonies per 2 x 105 nucleated marrow cells (Fig. 4) , slightly more than the 181±9 colonies per 2 x 105 cells (Fig. 3) in normal dogs not given endotoxin (P < 0.05).
The blood CFUc determinations during chronic endotoxin treatment showed that the wide swings in CFUc number seen in untreated grey collies (Fig. 3) were lost and replaced by more stable CFUc levels (Fig. 4) . Individual animal curves showed no visible periodicity. Blood CFUc in normal dogs treated with endotoxin increased significantly compared to dogs not given endotoxin (111±23 vs. 42±5 colonies/ml blood, P < 0.01). Blood CFUc during endotoxin treatment was lower in the grey collies than in normal dogs similarly treated (grey collies = 60±2 and normal dogs = 111 ±23 colonies/ml blood, P < 0.05).
Colonies grown from normal dog marrow and bloodl all showed obvious macrophages or granulocytic cells. Colonies from grey collies were similar to those seen in normal dog cultures and appeared the same in all phases of the neutrophil cycle. The morphologic types of colonies grown in endotoxin-treated normal and grey collie dogs appeared in frequencies similar to those in untreated dogs. b -I FIGURE 3 Circulating neutrophil counts for a representative grey collie (upper) are plotted with averaged data for bone marrow CFUc (middle) and blood CFUc (lower) in (Fig. 5) . Similarly, normal dogs given chronic endotoxin did not alter their CFUc suicide rates (27+2.5% without endotoxin vs. 28+3% with endotoxin, P > 0.30) (Fig. 5) (Fig. 5) .
CSA and endotoxin. Sequential hourly changes of serum CSA in normal and grey collie dogs given single, low-dose endotoxin injections (0.1 ,g/kg) were similar.
Normal dog CSA rose from 36+3 to 64±+14 colonies/ plate at 4 h after endotoxin, whereas grey collie CSA rose from 58+13 to 78+17 colonies/plate (Table  II) . By 24 h after endotoxin injection, serum CSA had returned to base line. The increase in CSA produced by this low dose of endotoxin was 20±9 colonies/plate in the grey collies and 28±15 in the normals (Table II) high-dose endotoxin (5 gg/kg) were not perfor the grey collies. Changes in serum CSA in successive phase, neutrophil cycle in the grey collies were ex before and during chronic endotoxin adminis For three dogs studied before endotoxin trE there was considerable variability of the serur In two dogs the values rose during neutr whereas in another there was no change (] When combined as averages by cycle day, the a] cycle of serum CSA in some animals is not see 7, left panel). Concurrent 2-wk periods of seru in individual normal dogs showed no periodicity; mean CSA values in concurrently normal dogs were 48±6 colonies/plate (Fig.   panel) .
Serum CSA in endotoxin-treated grey colli determined for specimens obtained after the dose of endotoxin was reached (5 gg/kg per each value represented the CSA 24 h after t] vious day's endotoxin dose. During endotoxi ment none of the grey collies showed risi falling values such as were sometimes seen treated grey collies (Fig. 6) . When serum CSA in endotoxin treated grey collies were avera cycle day, the curve was not significantly d from that in untreated grey collies (Fig. 7) . Normal dogs given chronic endotoxin did not show periodic changes in CSA; the mean serum CSA of endotoxin treated normal dogs was 50±3 colonies/plate, not different from the 48±6 colonies/plate of normal dogs not given endotoxin (P > 0.30) (Fig. 7) .
To further examine these findings we determined the immediate effects of individual doses of endotoxin on serum CSA values during chronic endotoxin treatment. Serum CSA measured before and --4h after doses is illustrated in Table II Our data show that untreated grey collies have wide periodic fluctuations in both blood and marrow CFUc numbers ( Fig. 2 and 3 (17) . WN'e finid much greater stability of the suicide rate, varying from 32% (eycle day 1) to 500% (cycle day 6) in the grey collies. Because cell-cycle status is highly dependenit upon the level of CSA stimulationi in the system (18), we believe this difference in suicide rates aindl the higher rate of colony yield in our svstem may reflect differences in the stimulators used. Therefore, from our observation, we do not believe the fluctuations in the CFUc pool in the grey collies can be explained solely from changes in cell-cycle status as has been suggested previously (17) .
Because we (19) and others (20) have previously found cyclic changes in CSA in urine and serum from dogs with cyclic hematopoiesis, the results of the serum CSA assays reported here were not expected. Although some cycles showed rising CSA during neutropenia, such a pattern was not uniformii. Cycles showing such rises tended to be associated with more severe illness in the dog, suggesting that endotoxemia secondary to severe neutropenia might be contributing to the CSA rise. Our data provide support for a similar hypothesis by Greenberg et al. (21) to explain changing CSA levels in human cyclic hematopoiesis.
The data presented here support the concept that cyclic hematopoiesis in grey collie dogs is a disorder of the stem cell regulatory system in which coImlmitted stem cell pool sizes fail to maintain homeostatic balance, and conse(luently produce widely fluctuating numbers of differentiated progeny. The disease process appears not to be mediated by serum CSA for two reasons. One is that in the untreated grey collie, cyclic fluctuations in CSA are not required for fluctuations in CFUe numbers. The second is that endotoxin treatment fails to alter serumii CSA levels when cyclic changes in CFUe anid bloo10 neutrophils are abolished. Although intramedullary levels of CSA could conceivably be mediatinig this effect of chronic endotoxin treatment without being reflected in serum CSA, we have no data to suggest such an effect.
The [3H]TdR suicide data reported here suggest that cyclic hematopoiesis is not a manifestation of simple switching on and off of proliferation within comiimitted stem cell compartments. The proliferative capacity of the precursor cell pool (measured as percent suicide for CFUc) does vary somewhat during the cycle period, but not to the degree that the CFUc pool size appears to change. We infer from these data that the size of the committed grainulocyte-macrophage progenitor cell pool is more dependenit upon the flux of pluripotent stem cells in and more differentiated progeny out than it is upoIn the self-replicationi of coimmitted stem cells within the pool. Because (luantitation of total marrow stem cell pools have not been made, however, such anl inferenice remainis speculative.
That repeated daily endotoxin injectionis in these dogs eliminate the cyclic changes in blood neutrophil counts, stabilize the bone marrow progenitor cell pool, and cause the marrow neutrophil reserves to resemble that of normal dogs suggests that endo-toxin acts at a key regulatory site early in hematopoiesis. Our data show that this is not associated with changes in serum CSA or in the [3H]TdR suicide rate of the CFUc. These findings suggest that endotoxin's effect is to increase the flux of cells into the committed stem cell compartment from the pluripotent stem cell pool.
